ANVS Annovis Bio Inc Company Future Sales Volume

ANVS (Annovis Bio, Inc.) - company brandmark

Annovis Bio, Inc. (ANVS) ensures a stable supply of molecules through diversified procurement channels. The company's target sales dynamics, with GURU.Markets data illustrated on this chart, has a fresh recorded value of 0.00. Market capitalization relies on grants for Parkinson's and Alzheimer's disease therapies, although geopolitical tensions and sanctions create risks for patent protection and the conduct of international research.

ANVS - Annovis Bio Corporation Company Projected Revenue over the range 07/04/2022 - 11/18/2026

Summary analytical data breakdowns for Annovis Bio, Inc. (ANVS)

- stock value and consensus price forecast:
Fundamental valuation:Annovis Bio Inc
Signature product of Annovis Bio Corporation

To objectively value an issuer, a portfolio manager requires a forecast of future cash flows. This indicator measures expected revenue, which serves as the basis for calculating market multiples. By analyzing the company's prospective sales volume, an investor determines the asset's capitalization potential while accounting for risks. For Annovis Bio, Inc. (ANVS), this metric reflects the commercial probability of bringing the drug buntuaneb to market. Consequently, this chart visualizes the monetization of multi-billion dollar R&D investments in the fight against neurodegenerative diseases.

Main competitors

Company Future Sales Volume BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Company Future Revenue|Company Projected Revenue Regencell RGC|Company Projected Revenue Volume AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Projected Sales Volume|XENE - Projected Sales Volume|VKTX: Projected Sales Volume|Company Expected Revenue SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Projected Sales Volume|DNLI: Company Future Revenue|Company Projected Revenue harmonybiosciences.com (HRMY)|Biohaven - Company Revenue Forecast|Projected Sales Volume AMLX (amylyx.com)|Trevi Pharma (TRVI) - Company Expected Sales Volume|Praxis Corp - Projected Sales Volume|Anavex Corp (AVXL) - Company Future Sales Volume|CBLL: Projected Sales Volume|Prothena Biosciences - Company Future Revenue|ALEC (alector.com) - Projected Sales Volume|Company Revenue Forecast ANNX (Annexon Biosciences)|Company Projected Revenue Omeros Corporation (OMER)|Neurogene Corp - Company Revenue Forecast|Company Projected Revenue AC Immune S.A. ACIU|Company Future Sales Voyager Therapeutics (VYGR)|Neumora - Projected Sales Volume|Company Expected Revenue SCLX|Tevogen Bio Inc. (TVGN) - Company Projected Revenue|Company Revenue Forecast ACOG|CGTX (cogrx.com) - Projected Sales Volume|Company Future Sales Volume inhibikase.com (IKT)|Company Projected Revenue Cassava Sciences Inc (SAVA)|Company Future Sales Assertio|Projected Sales Volume COYA (Coya Therapeutics, Inc.)|Company Projected Revenue Volume VTGN (VistaGen Therapeutics Inc)|OVID: Company Future Sales Volume|ABOS: Company Projected Revenue|CervoMed (CRVO) - Company Projected Revenue|Company Expected Sales Volume Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Projected Sales Volume|Company Revenue Forecast PEPG (PepGen)|Company Future Sales Volume JUNS (Jupiter Neurosciences, Inc.)|Projected Sales Volume relmada.com (RLMD)|Company Projected Revenue gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Company Expected Revenue|KLTO - Company Projected Revenue|Company Expected Sales Volume NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Company Projected Revenue|Company Revenue Forecast MTVA|Company Future Sales Volume NRXS|Company Future Sales Volume Helius Medical (HSDT)|Projected Sales Volume PASG|Neuphoria Therapeutics - Company Revenue Forecast|Company Projected Revenue Minerva Neurosciences, Inc. NERV|Projected Sales Volume Athira Pharma ATHA|ADXN: Company Future Sales Volume|Company Expected Sales Volume Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Company Projected Revenue|Company Expected Sales Volume Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Projected Sales Volume|Company Future Sales Volume Cortigent (CRGT)|Projected Sales Volume ATXI|BCLI - Company Expected Sales Volume|Projected Sales Volume CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Company Expected Sales Volume|ELYM - Company Projected Revenue|Company Sales Forecast intracellulartherapies.com (ITCI)|Longboard (LBPH) - Company Projected Revenue|Marinus Pharmaceuticals Inc - Company Future Revenue|Company Future Sales Volume NKGN|NeuroBo - Company Expected Revenue|Company Projected Revenue Sage Therapeutics, Inc (SAGE)|Company Future Sales Volume Synaptogenix SNPX|Trevena, Inc. - Company Future Sales Volume|VIGL: Company Revenue Forecast|WENA: Company Future Sales Volume|Company Expected Sales Volume Cerevel Therapeutics